Explore Starodub latest updates

Understanding new post-market surveillance requirements for medical devices

Palleos and Starodub Announce Strategic Partnership to Streamline Regulatory Pathways for Clinical Trials

Starodub B.V. is heading to China!

Festival of Biologics 30 September – 2 October 2025, Basel

Beyond Pride Month: Building Inclusion Every Day

GMP Guidelines: Rapid advancement of digital technologies and the implementation of AI

First Joint Clinical Assessments (JCAs) begin under EU HTA Regulation

Unified Quality Management Systems

Major Changes Ahead for CTD Modules 2 & 3: ICH Releases Draft M4Q(R2) for Public Consultation

Nonclinical safety assessment with New Approach Methodologies (NAMs): partner with us for regulatory success!Β 

Our 2025 company outing was unforgettable

MEB Planning Tool Mandatory from 1 July 2025

ICH Q1A Guideline – Stability Testing of Drug Substances and Products – open for consultation

Meet Starodub at HollandBIO Dutch Biotech Event – 27 June 2025

We’re excited to be part of the upcoming Life Sciences & Health Mission to Japan!

πŸš€ Powering Biotech Forward: Liberi Group & Starodub Join Forces 🀝

Expanding Our Expertise: Regulatory Affairs & Quality, Compliance & Improvements

New White Paper: The Challenges of Using nIVD MA ToC for Medical Device Registration

Gilliian Marland
Senior RA Consultant
Gilliian Marland

Let's Connect

Talk to an expert